Journal of Nanomedicine & Nanotechnology

Eduardo Sobarzo Sanchez

Eduardo Sobarzo Sanchez
Faculty of Pharmacy, Laboratory of Pharmaceutical Chemistry, Department of Organic Chemistry
University of Santiago de Compostela, Spain

Biography

Eduardo Sobarzo-Sánchez is an Associate Professor and Researcher at the Laboratory of Pharmaceutical Chemistry, Department of Organic Chemistry, Faculty of Pharmacy at the University of Santiago de Compostela (USC)".

. He received his B. Sc. (1996) and Ph.D. (2003) degrees from the Faculty of Sciences of the University of Chile in the study of the synthesis and chemical reactivity of a small and unknown group of isoquinoline alkaloids called “oxoisoaporphines”. On October, 2003, he got a Postdoctoral Fellow of the Ministerio de Asuntos Exteriores-Agencia Española de Cooperación Internacional (Spain) in the Faculty of Chemistry of the University of Santiago de Compostela for studying the synthesis and pharmacological behaviour of compounds derived from (-)-quinic acid as natural pesticides, and the synthesis and conformational characterization of molecular self-assembling peptide nanotubes for chelating metal ions as possible natural ionic channels. Dr. Eduardo Sobarzo-Sánchez is reviewer of some journals as Bioorganic & Medicinal Chemistry Letters, ARKIVOC, Journal of Molecular Structure, Current Topics in Medicinal Chemistry, Journal of Natural Products, and reviewer of international and national grants for Spain, Argentina and Chile. He is applicant of numerous grants in the scope of the pharmacology of synthetic and natural products, and as author of patents about the synthesis of modified drug-delivery and treatments against neurodegerative disorders and parasites.

Research Interest

His current research focuses on the design and synthesis of compounds from natural source as coumarin and 3-aza- and oxoisoaporphine derivatives as drugs in the treatment of cancer, platelet aggregation and monoamino oxidase (MAO) inhibitors. Also, he carry out the synthetic modification of natural cyclodextrin as better drug delivery linked to natural polymer as polycaprolactone (PCL), poly(lactic-co-glycolic acid (PLGA), etc in several studies on parasitic diseases.